SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India informs about Outcome of Board Meeting

23 Jul 2015 Evaluate

Granules India has informed that the Board of Directors of the Company at its meeting held on July 23, 2015, has approved the investment of up to Rs. 20 Crores in GIL Lifesciences, a wholly owned Indian Subsidiary of the Company, approved the issue of 1,86,56,000 warrants on preferential basis to Tyche Technologies, a promoter group Company, subject to approval of the members, at a price arrived at in accordance with the SEBI (ICDR) Regulations, 2009 and fixed the date of Extra-Ordinary General Meeting of the members of the Company on August 24, 2015 to consider the issue of warrants on preferential basis to Promoter Group Company.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×